Clinical Trials at University of Miami
As of September 2026, 236 paid clinical trials are recruiting at University of Miami, located at 1400 NW 10TH AVE, 10TH FLOOR, MIAMI, FL 33136-1000, phone (305) 243-5832 in Miami, Florida. Active studies at this site cover conditions such as Breast Cancer, Obesity and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Miami
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
CnF-DBS for Levodopa-Resistant FOG
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
240 clinical trials at University of Miami
·Clear filters·Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Study of COYA 302 for the Treatment of ALS
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Common conditions studied in Miami
- Breast Cancer (32 active studies)
- Obesity (24 active studies)
- Prostate Cancer (20 active studies)
- Overweight (17 active studies)
- Ulcerative Colitis (17 active studies)
- Multiple Myeloma (16 active studies)
Leading research sponsors in Miami
- University of Miami
- National Cancer Institute (NCI)
- Eli Lilly and Company
- AstraZeneca
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Miami?
There are approximately 1,356 recruiting clinical trials in Miami, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Miami pay participants?
Most recruiting trials in Miami compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Miami?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Miami?
The most common conditions under active study in Miami include Breast Cancer (32), Obesity (24), Prostate Cancer (20), Overweight (17), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Miami?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Miami on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Miami?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Miami?
Recruiting research sites in Miami include University of Miami, University of Miami Miller School of Medicine-Sylvester Cancer Center, Nicklaus Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Miami right now?
The largest active categories in Miami are Cancer & tumors (378), Neurology & pain (94), Diabetes & metabolic (71). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Miami?
University of Miami is located at 1400 NW 10TH AVE, 10TH FLOOR, MIAMI, FL 33136-1000. Use the Google Maps link in the intro above to get directions.
How do I contact University of Miami?
You can reach University of Miami by phone at (305) 243-5832. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.